Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.15252/emmm.202114532 http://scihub22266oqcxt.onion/10.15252/emmm.202114532 34260159!8687119!34260159     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       EMBO+Mol+Med 2021 ; 13 (8): e14532 Nephropedia Template TP {{tp|p=34260159|t=2021. Individual COVID-19 disease trajectories revealed by plasma proteomics |pdf=|usr=}}{{34260159}} gab.com Text Individual COVID-19 disease trajectories revealed by plasma proteomics JO: EMBO Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=34260159 #FOAvip Since the start of 2020, the world has been upended by the pandemic caused by the severe acute respiratory coronavirus type 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). It has not only led to a tragic loss of life and terrible economic costs but has also been met with an unprecedented response of the scientific and medical communities. In an effort to better understand this viral infection, scientists around the world generated the largest surge in research in documented history for any topic (Lever & Altman, 2021). A part of this work has included the need to better understand the impact of the virus on human proteins-the key machinery of the cell-and human physiology. In their recent study, Geyer and colleagues (Geyer et al, 2021) analyzed a total of 720 proteomes from longitudinal serum samples of 31 hospitalized COVID-19 patients and control individuals with COVID-19-like symptoms but not infected with SARS-CoV-2, providing a comprehensive characterization of the plasma proteome changes along the time course of infection. Twit Text FOAVip Individual COVID-19 disease trajectories revealed by plasma proteomics ????EMBO Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=34260159 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34260159 #FOAvip English Wikipedia <ref>{{Cite pmid|34260159}}</ref> Individual COVID-19 disease trajectories revealed by plasma proteomics #MMPMID34260159 Memon D; Barrio-Hernandez I; Beltrao P EMBO Mol Med 2021[Aug]; 13 (8): e14532 PMID34260159show ga Since the start of 2020, the world has been upended by the pandemic caused by the severe acute respiratory coronavirus type 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). It has not only led to a tragic loss of life and terrible economic costs but has also been met with an unprecedented response of the scientific and medical communities. In an effort to better understand this viral infection, scientists around the world generated the largest surge in research in documented history for any topic (Lever & Altman, 2021). A part of this work has included the need to better understand the impact of the virus on human proteins-the key machinery of the cell-and human physiology. In their recent study, Geyer and colleagues (Geyer et al, 2021) analyzed a total of 720 proteomes from longitudinal serum samples of 31 hospitalized COVID-19 patients and control individuals with COVID-19-like symptoms but not infected with SARS-CoV-2, providing a comprehensive characterization of the plasma proteome changes along the time course of infection. |*COVID-19[MESH] |*Proteomics[MESH] |Humans[MESH] |Pandemics[MESH] |Proteome[MESH]Individual COVID-19 disease trajectories revealed by plasma proteomics(epmc).pdf DeepDyve Pubget Overpricing